Tukysa (tucatinib) may represent a new patient-friendly option as a first line maintenance treatment possibility for patients ...
Clinicians treating patients with estrogen receptor (ER)-positive/HER2-negative metastatic breast cancer are navigating ...
So this looked at patients with ER-positive, HER2-Positive metastatic breast cancer who had received induction chemotherapy with H with or without P. Patients then were randomized to continue ...
Trastuzumab-based regimens were the primary treatment for older adults with advanced HER2-positive gastric cancer before immunotherapy became standard. The study highlights substantial economic ...
SECuRE trial to continue with no modifications to protocol following Safety Review Committee meeting
HIGHLIGHTSFollowing an interim data review of the Cohort Expansion Phase (Phase II) of the SECuRE trial, the Safety Review ...
The key drivers of increased investor interest in AstraZeneca are the strong performance of its oncology and cardiovascular ...
DelveInsight’s Metastatic Castration-Resistant Prostate Cancer pipeline report depicts a robust space with 75+ active players working to develop 75+ pipeline therapies for Metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback